Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES |
|---|---|
| Recipient Organization | Eden Medical, Inc. |
| Country | United States |
| Start Date | Sep 12, 2024 |
| End Date | Aug 31, 2025 |
| Duration | 353 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 11002915 |
Smart Foot Mat Abstract Eden Medical is pleased to develop the Smart Foot Mat (SfM), as a simple in-home appliance for stopping diabetic foot complications. We propose a powerful game-changing strategy having diabetics step on their smart mat at home once a day to monitor their foot oximetry and temperature over time to alert them early signs of ulcer onset. Near infrared spectroscopy (NIRS)
biomarkers provide a quantitative ulcer risk metric and can used to predict diabetic foot onset. Complications of diabetes that affect the lower extremities are common, complex, and costly. Diabetes is the most common metabolic disease worldwide with global cost of diabetes management including foot ulceration is now $825 billion dollars every year. Foot ulceration is
the most frequently recognized complication with 537 million adults who live with diabetes globally and it predicted to rise to 643 million by 2030. Recent investigations suggest that 40% of patients experience a recurrent diabetic foot ulcer (DFU) in the year after healing, and almost 60% within 3-years. Daily in-home monitoring will provide ulcer-free living for high-risk
diabetic patients.
Eden Medical, Inc.
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant